This device had the potential to change the cost base of the medical system due to lowering general GP visits. I'm not calling conspiracy, but maybe the FDA didn't want to do that at this time and had it's hands tied. It all gets back to money at the end of the day.
Ann: Update on US FDA De Novo Classification Request, page-24
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
